House
RoundsGuidelinesCalculatorsPricing
Sign inCreate account→
House

Citation-backed clinical intelligence for verified physicians.

Product

  • Rounds
  • Guidelines
  • Calculators
  • Pricing

Company

  • About
  • Editorial Policy

© 2026 House

For verified, licensed physicians. Not a substitute for clinical judgement.

Back to guidelines
Infectious Disease · RNTCP

Latent tuberculosis infection

RNTCP
A
Source:NTEP Guidance on TB Preventive Treatment 2024WHO Consolidated Guidelines on Tuberculosis: Tuberculosis Preventive Treatment (2024)
Verified Apr 2026
Ask House about this guideline

Red Flags

  • Active TB must be excluded BEFORE starting LTBI treatment — symptom screen, CXR, and (where indicated) sputum smear/Xpert[1]
  • Pre-existing severe liver disease — defer or avoid hepatotoxic LTBI regimens; balance individual risk[1]
  • Pregnancy with LTBI — defer treatment until postpartum unless very high TB risk; avoid rifapentine in pregnancy (limited data)[1]
  • Recent contact of MDR-TB case — standard LTBI regimens may not be effective; specialist input on fluoroquinolone-based prophylaxis[1]

First-line treatment

Interventions

  • Active screening of high-risk groups[1]
    Household contacts of TB cases (especially children <5 and PLHIV), healthcare workers, immunosuppressed, prisoners, healthcare-associated communities

First-line drug therapy

DrugClassAdultPaediatricNotes
Rifapentine + isoniazid (3HP)[1]Weekly rifamycin + isoniazidRifapentine 900 mg + isoniazid 900 mg PO once weekly × 12 dosesPer weight, age ≥2 years per NTEP/WHOPreferred regimen for HIV-negative and select HIV-positive individuals; better completion than 6H
Rifapentine + isoniazid (1HP)[1]Daily 1-month rifapentine + isoniazidRifapentine 600 mg + isoniazid 300 mg PO daily × 28 daysAdults and ≥13 yearsShortest regimen, PLHIV indication; high completion rate
Rifampicin (4R)[1]Daily rifampicin × 4 months10 mg/kg PO daily (max 600 mg) × 4 months10–20 mg/kg/dayAlternative; better completion than 6H; consider with INH-resistance contacts
Isoniazid (6H)[1]Daily isoniazid × 6 months5 mg/kg (max 300 mg) PO daily × 6 months with pyridoxine 10 mg daily10 mg/kg/day max 300 mgTraditional regimen; lower completion rates than shorter alternatives but still effective
Rifapentine + isoniazid (3HP)[1]
Weekly rifamycin + isoniazid
Adult
Rifapentine 900 mg + isoniazid 900 mg PO once weekly × 12 doses
Paediatric
Per weight, age ≥2 years per NTEP/WHO
Preferred regimen for HIV-negative and select HIV-positive individuals; better completion than 6H
Rifapentine + isoniazid (1HP)[1]
Daily 1-month rifapentine + isoniazid
Adult
Rifapentine 600 mg + isoniazid 300 mg PO daily × 28 days
Paediatric
Adults and ≥13 years
Shortest regimen, PLHIV indication; high completion rate
Rifampicin (4R)[1]
Daily rifampicin × 4 months
Adult
10 mg/kg PO daily (max 600 mg) × 4 months
Paediatric
10–20 mg/kg/day
Alternative; better completion than 6H; consider with INH-resistance contacts
Isoniazid (6H)[1]
Daily isoniazid × 6 months
Adult
5 mg/kg (max 300 mg) PO daily × 6 months with pyridoxine 10 mg daily
Paediatric
10 mg/kg/day max 300 mg
Traditional regimen; lower completion rates than shorter alternatives but still effective

Safety-net

  1. Take LTBI treatment exactly as prescribed; missed doses or premature stop reduces protection[1]
  2. Watch for jaundice, severe vomiting, rash, or numb hands/feet — same-day medical review (drug toxicity); pyridoxine reduces neuropathy risk on isoniazid[1]
  3. Tell other clinicians and your dentist that you are on rifampicin/rifapentine — many drug interactions (oral contraceptives, anticoagulants, antiretrovirals)[1]

Referral criteria

  • Suspected active TB during LTBI workup (symptoms, CXR abnormality)TB specialist; do NOT give LTBI monotherapy alone[1]
  • Contact of MDR-TB casePMDT centre for individualised prophylaxis[1]
  • Severe ATT-related liver injury during LTBI therapyHospital admission; pause; sequential reintroduction under specialist[1]

Clinical summary

Identification and treatment of latent TB infection (LTBI) in high-risk groups; shorter rifamycin-based regimens preferred over 6-month isoniazid.

References

  1. 1.NTEP Guidance on TB Preventive Treatment 2024; WHO Consolidated Guidelines on Tuberculosis: Tuberculosis Preventive Treatment (2024)

On this page

  • Red flags
  • First-line treatment
  • Safety-net
  • Referral
  • References